Implementation of Diagnostic Biomarker Testing in Lung Cancer: Real-World Data in Japan

被引：0
|
作者：
Yatabe, Y. [1 ]
Yoshiki, Y. [2 ]
Matsumura, K. [2 ]
Togo, K. [2 ]
Kikkawa, H. [2 ]
Masters, E. [3 ]
Iadeluca, L. [3 ]
Becnel, L. [4 ]
Emir, B. [3 ]
Wiltshire, R. [5 ]
Nishio, K. [6 ]
机构：
[1] Natl Canc Ctr, Dept Diagnost Pathol, Tokyo, Japan
[2] Pfizer Japan Inc, Tokyo, Japan
[3] Pfizer Inc, New York, NY USA
[4] Pfizer Inc, Westlake, TX USA
[5] Pfizer Ltd, Walton Oaks, England
[6] Kindai Univ, Sch Med, Dept Genome Biol, Osaka, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
real world data; lung cancer; companion diagnosis;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA08.08
引用
收藏
页码：S162 / S162
页数：1
相关论文
共 50 条
  • [1] Real-world data of multiple diagnostic biomarker testing for lung cancer patients in Japan
    Yatabe, Yasushi
    Nishio, Makoto
    Takahashi, Toshiaki
    Nishino, Kazumi
    Yoshiki, Yasumasa
    Togo, Kanae
    Emir, Birol
    Iadeluca, Laura
    Nishio, Kazuto
    ANNALS OF ONCOLOGY, 2021, 32 : S300 - S300
  • [2] Real-World Data of NGS Diagnostic Biomarker Testing for Lung Cancer Patients in Japan
    Takahashi, T.
    Nishio, M.
    Yatabe, Y.
    Nishino, K.
    Yoshiki, Y.
    Shiraiwa, N.
    Emir, B.
    Iadeluca, L.
    Nishio, K.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1151 - S1152
  • [3] Real-world study of next-generation sequencing diagnostic biomarker testing for patients with lung cancer in Japan
    Takahashi, Toshiaki
    Nishio, Makoto
    Nishino, Kazumi
    Yoshiki, Yasumasa
    Shiraiwa, Naoko
    Emir, Birol
    Iadeluca, Laura
    Yatabe, Yasushi
    Nishio, Kazuto
    CANCER SCIENCE, 2023, 114 (06) : 2524 - 2533
  • [4] Real-World Evidence of Diagnostic Testing for Driver Oncogene Mutations in Lung Cancer in Japan
    Yatabe, Yasushi
    Yoshiki, Yasumasa
    Matsumura, Koichi
    Togo, Kanae
    Kikkawa, Hironori
    Iadeluca, Laura
    Li, Benjamin
    Nishio, Kazuto
    JTO CLINICAL AND RESEARCH REPORTS, 2021, 2 (03):
  • [5] Editorial: Real-world data and real-world evidence in lung cancer
    Gristina, Valerio
    Eze, Chukwuka
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [6] Molecular Testing in Lung Cancer: Still Big Gap in Implementation for Real-World Use
    Ahn, Myung-Ju
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (09) : 1399 - 1400
  • [7] Disparities in biomarker testing in ovarian cancer: a real-world analysis
    Smith, Anna Jo Bodurtha
    Alvarez, Rafael
    Heintz, Jonathan
    Haggerty, Ashley
    Ko, Emily M.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2023, 228 (01) : 98 - 100
  • [8] Proposal of real-world solutions for the implementation of predictive biomarker testing in patients with operable non-small cell lung cancer
    Hofman, Paul
    Christopoulos, Petros
    D'Haene, Nicky
    Gosney, John
    Normanno, Nicola
    Schuuring, Ed
    Tsao, Ming-Sound
    Quinn, Christine
    Russell, Jayne
    Keating, Katherine E.
    Lopez-Rios, Fernando
    LUNG CANCER, 2025, 201
  • [9] Assessing Oncologists' Adoption of Biomarker Testing in Metastatic Colorectal Cancer Using Real-World Data
    Iyer, Pritish
    Deng, Mengying
    Handorf, Elizabeth A.
    Nakhoda, Shazia
    Dotan, Efrat
    JNCI CANCER SPECTRUM, 2022, 6 (06)
  • [10] Assessing real-world biomarker testing rates in metastatic colon cancer
    Nakhoda, Shazia
    Deng, Mengying
    Iyer, Pritish
    Handorf, Elizabeth A.
    Jain, Rishi
    Meropol, Neal J.
    Dotan, Efrat
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
12345